Acceleron Pharma Inc EBIT margin
Was ist das EBIT margin von Acceleron Pharma Inc?
EBIT margin von Acceleron Pharma Inc ist -225.99%
Was ist die Definition von EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acceleron Pharma Inc
Was macht Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Unternehmen mit ebit margin ähnlich Acceleron Pharma Inc
- Lumos Diagnostics hat EBIT margin von -231.17%
- Fiore Cannabis hat EBIT margin von -228.94%
- CHF Solutions Inc hat EBIT margin von -228.85%
- Accelerate Diagnostics Inc hat EBIT margin von -227.57%
- Affimed N.V hat EBIT margin von -227.50%
- Tellurian Inc hat EBIT margin von -226.66%
- Acceleron Pharma Inc hat EBIT margin von -225.99%
- Frequency Exchange hat EBIT margin von -225.62%
- WS Industries (India) hat EBIT margin von -225.31%
- Acorda Therapeutics Inc hat EBIT margin von -224.84%
- Fangdd Network Ltd hat EBIT margin von -224.41%
- DSS Inc hat EBIT margin von -224.16%
- ClearSign Technologies Corp hat EBIT margin von -222.55%